BESREMi

Indicated For

polycythemia vera

About This Medication

# PharmaEssentia SOURCE Patient Assistance Program Patient Guide: How to Get BESREMi (ropeginterferon alfa-2b-njft) at Low or No Cost BESREMi (ropeginterferon alfa-2b-njft) is a prescription medication used to treat adults with polycythemia vera, a type of blood cancer characterized by overproduction of red blood cells. The **PharmaEssentia SOURCE Patient Assistance Program** from manufacturer **PharmaEssentia** helps **uninsured, underinsured, or patients facing insurance delays/gaps** access BESREMi **at no cost or as little as $0 per month** if they meet financial and other eligibility criteria.[1][2][5][6] ## Who Qualifies for the Program? This program is designed for patients who struggle to afford BESREMi due to lack of insurance or limited coverage. **Eligible patients typically include:** - Uninsured individuals - Underinsured patients with high copays, coinsurance, or deductibles - Those experiencing temporary insurance delays or coverage gaps[2][5][6] You must reside in the **US or a US territory**, have a valid prescription from a US-licensed physician, and meet financial need requirements based on household income and size. The program verifies your insurance (if any) and financial situation to determine the best support option, which may include free medication through the patient assistance program (PAP).[3][5][7] **Important:** Restrictions apply, and eligibility is subject to change. A PharmaEssentia SOURCE Case Manager will review your details to confirm qualification.[1][2] ## About BESREMi (ropeginterferon alfa-2b-njft) **BESREMi** is a long-acting interferon therapy administered as a subcutaneous injection every 2 weeks or less frequently after dose titration. It's indicated for adults with polycythemia vera to reduce the frequency of phlebotomy procedures and improve hematocrit control. Unlike daily interferons, BESREMi offers convenient dosing that allows many patients to self-administer at home after training. Common side effects include flu-like symptoms, fatigue, and injection site reactions. It carries a **Boxed Warning** for serious disorders like psychiatric, autoimmune, cardiovascular, and infectious risks—discuss these with your doctor. Always follow your prescribing information and report side effects to PharmaEssentia at 1-800-999-2449 or FDA at 1-800-FDA-1088.[9] PharmaEssentia SOURCE provides additional support like injection training, insurance navigation, and titration guidance to help you start and stay on treatment successfully.[4][5][7] ## Income Eligibility Breakdown Specific Federal Poverty Level (FPL) percentages or exact income thresholds are not publicly detailed, as eligibility is determined case-by-case based on **annual gross household income**, **number of household members**, and other financial factors. You must provide proof of income during enrollment.[3] Here's a general guide based on program requirements: | Household Size | Estimated Income Consideration | Notes | |---------------|-------------------------------|--------| | 1 (Individual) | Based on financial need verification | Uninsured/underinsured prioritized[3][5] | | 2 (Couple) | Household income reviewed | Includes all members[3] | | 3 | Case-by-case assessment | Proof required[3] | | 4+ | Scaled by family size | Reside in US/US territory[5] | **Contact the program at (833) 546-7473 or 800-700-5053** for your personalized eligibility check. Providing complete financial info speeds up approval.[1][3] ## Insurance Requirements The program supports various scenarios: - **Uninsured:** Eligible for free medication (PAP).[2][5][6] - **Commercial/Private Insurance:** Copay/coinsurance/deductible assistance up to $0 monthly for eligible patients.[6][9] - **Medicare/Medicaid:** Broad coverage exists, but PAP helps with gaps; confirm with Case Manager.[7][9] - **Insurance Delays/Gaps:** Temporary supply available.[2][4] PharmaEssentia SOURCE contacts your insurer to verify benefits and explores all options.[1][4] ## Step-by-Step Application Process Enrolling is straightforward with **two main methods**. Work with your doctor.[1][4][5] 1. **By Phone (Recommended):** Call **800-700-5053** (Mon-Fri, 8 AM-8 PM ET). A Case Manager guides you and your doctor.[1][4] 2. **Enrollment Form:** - Download from pharmaessentiasource.com. - Complete your section (contact info, insurance cards, household size, annual gross income). - Doctor completes prescription and signs. - Fax to **800-700-5065**.[3][5] **Required Documents:** - Proof of income (e.g., tax returns, pay stubs) - Proof of residency (e.g., utility bill) - Prescription for BESREMi - Insurance status documentation (cards or denial letters)[3] Once submitted, your Case Manager: - Verifies insurance. - Contacts you to discuss financial support. - Arranges medication if approved.[1][4] Sign consents for info sharing.[3] ## Timeline and Delivery Processing time varies based on completeness, but aim for quick start: - **Enrollment to Review:** Days, with follow-up if info missing.[1] - **Approval:** Case Manager calls with next steps; temporary supply for delays.[2][4] - **Delivery:** Shipped free to your home or doctor's office.[Program Details] Expect ongoing support post-approval, including refills and reauthorization.[4] ## Alternatives if Denied or Ineligible - **Copay Program:** Visit BESREMiCopay.com for commercial insurance help.[2][6] - **Other Resources:** Case Managers connect to external organizations for treatment costs.[2][6] - **Appeal:** Provide additional docs or updated income. - **No Biosimilars:** None available.[Program Details] - Reapply if circumstances change. ## Reauthorization **Reauthorization is required** periodically. Your Case Manager handles refill prescriptions and eligibility checks.[Program Details][4] ## Disclaimer This guide is for informational purposes based on available program details as of latest updates. Eligibility, benefits, and terms can change; always verify with PharmaEssentia SOURCE at 800-700-5053. Not a substitute for medical advice—consult your doctor. Program does not guarantee coverage. See full Prescribing Information, including Boxed Warning.[1][2][9] (Word count: 1028)

Program information last verified: March 30, 2026